Form4insider filings, from the source

SEC Form 4 · accession 0001808365-26-000004

Keros Therapeutics, Inc. · KROS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jun 4, 2026
Accepted (ET)
Jun 8, 2026 · 4:36 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001664710

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Jun 4, 2026S2,625$10.73D10,958D
Common StockF3holding———150,047ISee footnote
Common StockF4holding———102,233ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses